Evidence map›Paper›PMID 34209818›Full record

ArticleGenes2021

Toward a Coronavirus Knowledge Graph.

Peng Zhang, Yi Bu, Peng Jiang, Xiaowen Shi, Bing Lun, Chongyan Chen, Arida Ferti Syafiandini, Ying Ding, Min Song

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Peng ZhangDepartment of Computer Science and Technology, Tsinghua University, Beijing 100084, China.
Yi BuDepartment of Information Management, Peking University, Beijing 100871, China.ORCID 0000-0003-2549-4580
Peng JiangBeijing Knowledge Atlas Technology Co., Ltd., Beijing 100043, China.
Xiaowen ShiBeijing Knowledge Atlas Technology Co., Ltd., Beijing 100043, China.
Bing LunBeijing Knowledge Atlas Technology Co., Ltd., Beijing 100043, China.
Chongyan ChenSchool of Information, University of Texas at Austin, Austin, TX 78701, USA.ORCID 0000-0003-3188-6652
Arida Ferti SyafiandiniDepartment of Library and Information Science, Yonsei University, Seoul 03722, Korea.
Ying DingSchool of Information, University of Texas at Austin, Austin, TX 78701, USA.
Min SongDepartment of Library and Information Science, Yonsei University, Seoul 03722, Korea.
The University of Texas at Austin · USYonsei University · KRPeking University · CNTsinghua University · CN

Funding

National Research Foundation of Korea NRF-2019R1A2C2002577National Science Foundation in the United States NSF Rapid 2028717
6 · The paper itself

Abstract

This study builds a coronavirus knowledge graph (KG) by merging two information sources. The first source is Analytical Graph (AG), which integrates more than 20 different public datasets related to drug discovery. The second source is CORD-19, a collection of published scientific articles related to COVID-19. We combined both chemo genomic entities in AG with entities extracted from CORD-19 to expand knowledge in the COVID-19 domain. Before populating KG with those entities, we perform entity disambiguation on CORD-19 collections using Wikidata. Our newly built KG contains at least 21,700 genes, 2500 diseases, 94,000 phenotypes, and other biological entities (e.g., compound, species, and cell lines). We define 27 relationship types and use them to label each edge in our KG. This research presents two cases to evaluate the KG's usability: analyzing a subgraph (ego-centered network) from the angiotensin-converting enzyme (ACE) and revealing paths between biological entities (hydroxychloroquine and IL-6 receptor; chloroquine and STAT1). The ego-centered network captured information related to COVID-19. We also found significant COVID-19-related information in top-ranked paths with a depth of three based on our path evaluation.

Indexed as

COVID-19Knowledge BasesChloroquineComputer GraphicsDatabases, FactualHemorrhagic Fever, EbolaHumansHydroxychloroquinePattern Recognition, AutomatedPeptidyl-Dipeptidase APubMedReceptors, Interleukin-6SARS-CoV-2STAT1 Transcription FactorACE protein, humanChloroquineHydroxychloroquinePeptidyl-Dipeptidase AReceptors, Interleukin-6STAT1 protein, humanSTAT1 Transcription Factorknowledge base managementknowledge engineering methodologiesknowledge management applications

Identifiers

PMID34209818
PMCPMC8307964
OpenAlexW3174998205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.